Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ilse

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Neurological Research and Practice|August 23, 2024
User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational studySusanne Spittel, Thomas Meyer, Ute Weyen, et al.
Neurological Research and Practice|September 27, 2025
Response to Fortin-Bédard et al. "User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study"Susanne Spittel, Thomas Meyer, Ute Weyen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 3, 2021
Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborationsPaul Lingor, Jan C Koch, Jeffrey M Statland, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 1, 2022
Remote digital assessment of amyotrophic lateral sclerosis functional rating scale - a multicenter observational studyThomas Meyer, Susanne Spittel, Torsten Grehl, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 11, 2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter studySusanne Spittel, Torsten Grehl, Patrick Weydt, et al.
Neurological Research and Practice|April 9, 2026
Between guidelines and reality: expert neurologists' perspectives on structural resources for ALS care in GermanyKatharina Linse, Dorothée Lulé, Florian Schöberl, et al.
Orphanet Journal of Rare Diseases|September 8, 2025
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational studyClaudia D Wurster, Benjamin Stolte, Tobias Kessler, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neurological Research and Practice|August 23, 2024
User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational studySusanne Spittel, Thomas Meyer, Ute Weyen, et al.
Neurological Research and Practice|September 27, 2025
Response to Fortin-Bédard et al. "User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study"Susanne Spittel, Thomas Meyer, Ute Weyen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 3, 2021
Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborationsPaul Lingor, Jan C Koch, Jeffrey M Statland, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 1, 2022
Remote digital assessment of amyotrophic lateral sclerosis functional rating scale - a multicenter observational studyThomas Meyer, Susanne Spittel, Torsten Grehl, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 11, 2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter studySusanne Spittel, Torsten Grehl, Patrick Weydt, et al.
Neurological Research and Practice|April 9, 2026
Between guidelines and reality: expert neurologists' perspectives on structural resources for ALS care in GermanyKatharina Linse, Dorothée Lulé, Florian Schöberl, et al.
Orphanet Journal of Rare Diseases|September 8, 2025
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational studyClaudia D Wurster, Benjamin Stolte, Tobias Kessler, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 2